• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021

    11/29/21 10:02:44 AM ET
    $ACXP
    $ADGI
    $AFRM
    $ALLE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACXP alert in real time by email

     

    Upgrades

    • According to Odeon Capital, the prior rating for Wells Fargo & Co (NYSE:WFC) was changed from Hold to Buy. In the third quarter, Wells Fargo showed an EPS of $1.17, compared to $0.42 from the year-ago quarter. The current stock performance of Wells Fargo shows a 52-week-high of $52.56 and a 52-week-low of $27.28. Moreover, at the end of the last trading period, the closing price was at $48.43.
    • For HeadHunter Group PLC (NASDAQ:HHR), UBS upgraded the previous rating of Neutral to Buy. In the third quarter, HeadHunter Group showed an EPS of $0.54, compared to $0.20 from the year-ago quarter. The current stock performance of HeadHunter Group shows a 52-week-high of $68.18 and a 52-week-low of $24.25. Moreover, at the end of the last trading period, the closing price was at $51.70.
    • According to Stephens & Co., the prior rating for Truist Financial Corp (NYSE:TFC) was changed from Equal-Weight to Overweight. Truist Financial earned $1.42 in the third quarter, compared to $0.97 in the year-ago quarter. At the moment, the stock has a 52-week-high of $65.42 and a 52-week-low of $45.44. Truist Financial closed at $60.08 at the end of the last trading period.
    • According to Citigroup, the prior rating for TJX Companies Inc (NYSE:TJX) was changed from Neutral to Buy. TJX Companies earned $0.84 in the third quarter, compared to $0.71 in the year-ago quarter. At the moment, the stock has a 52-week-high of $76.94 and a 52-week-low of $61.15. TJX Companies closed at $69.36 at the end of the last trading period.
    • Citigroup upgraded the previous rating for Burlington Stores Inc (NYSE:BURL) from Neutral to Buy. Burlington Stores earned $1.36 in the third quarter, compared to $0.29 in the year-ago quarter. At the moment, the stock has a 52-week-high of $357.34 and a 52-week-low of $217.38. Burlington Stores closed at $283.85 at the end of the last trading period.
    • According to Truist Securities, the prior rating for MGP Ingredients Inc (NASDAQ:MGPI) was changed from Hold to Buy. In the third quarter, MGP Ingredients showed an EPS of $1.09, compared to $0.61 from the year-ago quarter. The stock has a 52-week-high of $79.52 and a 52-week-low of $42.42. At the end of the last trading period, MGP Ingredients closed at $73.51.
    • For Copa Holdings SA (NYSE:CPA), Raymond James upgraded the previous rating of Outperform to Strong Buy. For the third quarter, Copa Holdings had an EPS of $0.70, compared to year-ago quarter EPS of $2.86. At the moment, the stock has a 52-week-high of $94.91 and a 52-week-low of $64.66. Copa Holdings closed at $71.77 at the end of the last trading period.
    • Morgan Stanley upgraded the previous rating for Adagio Therapeutics Inc (NASDAQ:ADGI) from Equal-Weight to Overweight.
    • For Surgery Partners Inc (NASDAQ:SGRY), Stifel upgraded the previous rating of Hold to Buy. For the third quarter, Surgery Partners had an EPS of $0.05, compared to year-ago quarter EPS of $0.53. At the moment, the stock has a 52-week-high of $69.58 and a 52-week-low of $24.20. Surgery Partners closed at $43.74 at the end of the last trading period.
    • For argenx SE (NASDAQ:ARGX), Piper Sandler upgraded the previous rating of Neutral to Overweight. In the third quarter, argenx showed an EPS of $4.40, compared to $3.96 from the year-ago quarter. The current stock performance of argenx shows a 52-week-high of $382.15 and a 52-week-low of $248.21. Moreover, at the end of the last trading period, the closing price was at $276.10.
    • Raymond James upgraded the previous rating for Bumble Inc (NASDAQ:BMBL) from Market Perform to Outperform. For the third quarter, Bumble had an EPS of $0.06, compared to year-ago quarter EPS of $0.01. The current stock performance of Bumble shows a 52-week-high of $84.80 and a 52-week-low of $33.29. Moreover, at the end of the last trading period, the closing price was at $33.83.
    • For Hyatt Hotels Corp (NYSE:H), JP Morgan upgraded the previous rating of Neutral to Overweight. In the third quarter, Hyatt Hotels showed an EPS of $2.31, compared to $1.48 from the year-ago quarter. The current stock performance of Hyatt Hotels shows a 52-week-high of $94.92 and a 52-week-low of $65.44. Moreover, at the end of the last trading period, the closing price was at $78.13.

    See all analyst ratings upgrades.

     

    Downgrades

    • For Apellis Pharmaceuticals Inc (NASDAQ:APLS), Roth Capital downgraded the previous rating of Buy to Neutral. Apellis Pharmaceuticals earned $1.57 in the third quarter, compared to $1.79 in the year-ago quarter. The stock has a 52-week-high of $73.00 and a 52-week-low of $27.50. At the end of the last trading period, Apellis Pharmaceuticals closed at $43.54.
    • For Jumia Technologies AG (NYSE:JMIA), Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. At the moment, the stock has a 52-week-high of $69.89 and a 52-week-low of $11.96. Jumia Technologies closed at $13.64 at the end of the last trading period.
    • For Saia Inc (NASDAQ:SAIA), Deutsche Bank downgraded the previous rating of Buy to Hold. In the third quarter, Saia showed an EPS of $2.86, compared to $1.56 from the year-ago quarter. The stock has a 52-week-high of $365.50 and a 52-week-low of $171.00. At the end of the last trading period, Saia closed at $335.83.
    • For U.S. Bancorp (NYSE:USB), Stephens & Co. downgraded the previous rating of Overweight to Equal-Weight. In the third quarter, U.S. Bancorp showed an EPS of $1.30, compared to $0.99 from the year-ago quarter. The current stock performance of U.S. Bancorp shows a 52-week-high of $63.01 and a 52-week-low of $42.47. Moreover, at the end of the last trading period, the closing price was at $57.50.
    • According to Deutsche Bank, the prior rating for Canadian Pacific Railway Ltd (NYSE:CP) was changed from Buy to Hold. For the third quarter, Canadian Pacific Railway had an EPS of $0.70, compared to year-ago quarter EPS of $0.62. At the moment, the stock has a 52-week-high of $404.43 and a 52-week-low of $64.37. Canadian Pacific Railway closed at $71.31 at the end of the last trading period.
    • Deutsche Bank downgraded the previous rating for United Parcel Service Inc (NYSE:UPS) from Buy to Hold. For the third quarter, United Parcel Service had an EPS of $2.71, compared to year-ago quarter EPS of $2.28. The current stock performance of United Parcel Service shows a 52-week-high of $220.24 and a 52-week-low of $154.76. Moreover, at the end of the last trading period, the closing price was at $205.30.
    • For Beacon Roofing Supply Inc (NASDAQ:BECN), Truist Securities downgraded the previous rating of Buy to Hold. For the fourth quarter, Beacon Roofing Supply had an EPS of $1.78, compared to year-ago quarter EPS of $1.30. The current stock performance of Beacon Roofing Supply shows a 52-week-high of $60.93 and a 52-week-low of $35.86. Moreover, at the end of the last trading period, the closing price was at $53.77.
    • According to Wells Fargo, the prior rating for Greif Inc (NYSE:GEF) was changed from Overweight to Equal-Weight. In the third quarter, Greif showed an EPS of $1.93, compared to $0.85 from the year-ago quarter. The current stock performance of Greif shows a 52-week-high of $72.00 and a 52-week-low of $44.16. Moreover, at the end of the last trading period, the closing price was at $67.66.
    • According to Citigroup, the prior rating for Merck & Co Inc (NYSE:MRK) was changed from Buy to Neutral. For the third quarter, Merck & Co had an EPS of $1.75, compared to year-ago quarter EPS of $1.74. The current stock performance of Merck & Co shows a 52-week-high of $91.40 and a 52-week-low of $15.32. Moreover, at the end of the last trading period, the closing price was at $79.16.
    • Piper Sandler downgraded the previous rating for Hudson Pacific Properties Inc (NYSE:HPP) from Overweight to Neutral. For the third quarter, Hudson Pacific Properties had an EPS of $0.50, compared to year-ago quarter EPS of $0.43. The current stock performance of Hudson Pacific Properties shows a 52-week-high of $30.35 and a 52-week-low of $22.75. Moreover, at the end of the last trading period, the closing price was at $25.33.
    • According to Jefferies, the prior rating for CyrusOne Inc (NASDAQ:CONE) was changed from Buy to Hold. In the third quarter, CyrusOne showed an EPS of $1.02, compared to $0.96 from the year-ago quarter. The current stock performance of CyrusOne shows a 52-week-high of $89.92 and a 52-week-low of $61.64. Moreover, at the end of the last trading period, the closing price was at $89.24.

    See all analyst ratings downgrades.

     

    Initiations

    • EF Hutton initiated coverage on ComSovereign Holding Corp (NASDAQ:COMS) with a Buy rating. The price target for ComSovereign Holding is set to $2.10. At the moment, the stock has a 52-week-high of $5.78 and a 52-week-low of $1.01. ComSovereign Holding closed at $1.15 at the end of the last trading period.
    • William Blair initiated coverage on Allbirds Inc (NASDAQ:BIRD) with an Outperform rating.
    • With an Overweight rating, Stephens & Co. initiated coverage on Cadre Holdings Inc (NYSE:CDRE). The price target seems to have been set at $23.00 for Cadre Hldgs.
    • With an Outperform rating, Oppenheimer initiated coverage on Nerdwallet Inc (NASDAQ:NRDS). The price target seems to have been set at $30.00 for Nerdwallet.
    • Maxim Group initiated coverage on Worksport Ltd (NASDAQ:WKSP) with a Buy rating. The price target for Worksport is set to $8.00. In the third quarter, Worksport showed an EPS of $0.15, compared to $0.21 from the year-ago quarter. The current stock performance of Worksport shows a 52-week-high of $9.09 and a 52-week-low of $0.12. Moreover, at the end of the last trading period, the closing price was at $3.86.
    • With a Buy rating, Maxim Group initiated coverage on Acurx Pharmaceuticals Inc (NASDAQ:ACXP). The price target seems to have been set at $12.00 for Acurx Pharmaceuticals. For the third quarter, Acurx Pharmaceuticals had an EPS of $0.46, compared to year-ago quarter EPS of $0.21. At the moment, the stock has a 52-week-high of $8.74 and a 52-week-low of $3.71. Acurx Pharmaceuticals closed at $4.89 at the end of the last trading period.
    • With a Equal-Weight rating, Morgan Stanley initiated coverage on Nerdwallet Inc (NASDAQ:NRDS). The price target seems to have been set at $24.00 for Nerdwallet.
    • Morgan Stanley initiated coverage on Arhaus Inc (NASDAQ:ARHS) with a Equal-Weight rating. The price target for Arhaus is set to $12.00.
    • For Evotec SE (NASDAQ:EVO), Cowen & Co. initiated coverage, by setting the current rating at Outperform.
    • With a Hold rating, Stifel initiated coverage on Cadre Holdings Inc (NYSE:CDRE). The price target seems to have been set at $20.00 for Cadre Hldgs.
    • With an Outperform rating, JMP Securities initiated coverage on iBio Inc (AMEX:IBIO). The price target seems to have been set at $1.50 for iBio. In the first quarter, iBio showed an EPS of $0.04, compared to $0.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.83 and a 52-week-low of $0.56. iBio closed at $0.66 at the end of the last trading period.
    • Truist Securities initiated coverage on Nerdwallet Inc (NASDAQ:NRDS) with a Buy rating. The price target for Nerdwallet is set to $30.00.
    • With a Buy rating, BTIG initiated coverage on Freeline Therapeutics Holdings PLC (NASDAQ:FRLN). The price target seems to have been set at $10.00 for Freeline Therapeutics. At the moment, the stock has a 52-week-high of $18.88 and a 52-week-low of $2.15. Freeline Therapeutics closed at $2.31 at the end of the last trading period.
    • With a Buy rating, BTIG initiated coverage on MDxHealth SA (NASDAQ:MDXH). The price target seems to have been set at $15.00 for MDxHealth.
    • Atlantic Equities initiated coverage on Allegion PLC (NYSE:ALLE) with an Overweight rating. The price target for Allegion is set to $155.00. Allegion earned $1.56 in the third quarter, compared to $1.67 in the year-ago quarter. The current stock performance of Allegion shows a 52-week-high of $148.69 and a 52-week-low of $106.52. Moreover, at the end of the last trading period, the closing price was at $129.37.
    • B. Riley Securities initiated coverage on Cadre Holdings Inc (NYSE:CDRE) with a Buy rating. The price target for Cadre Hldgs is set to $26.00.
    • Needham initiated coverage on Inozyme Pharma Inc (NASDAQ:INZY) with a Buy rating. The price target for Inozyme Pharma is set to $23.00. In the third quarter, Inozyme Pharma showed an EPS of $0.60, compared to $1.55 from the year-ago quarter. The current stock performance of Inozyme Pharma shows a 52-week-high of $29.46 and a 52-week-low of $7.66. Moreover, at the end of the last trading period, the closing price was at $8.00.
    • With a Neutral rating, Piper Sandler initiated coverage on Affirm Holdings Inc (NASDAQ:AFRM). The price target seems to have been set at $127.00 for Affirm Holdings. The stock has a 52-week-high of $176.65 and a 52-week-low of $46.50. At the end of the last trading period, Affirm Holdings closed at $136.98.
    • With a Neutral rating, Piper Sandler initiated coverage on Synchrony Financial (NYSE:SYF). The price target seems to have been set at $52.00 for Synchrony Finl. Synchrony Finl earned $2.00 in the third quarter, compared to $0.63 in the year-ago quarter. The current stock performance of Synchrony Finl shows a 52-week-high of $52.49 and a 52-week-low of $30.43. Moreover, at the end of the last trading period, the closing price was at $47.68.

    See all analyst ratings initiations.

    Get the next $ACXP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACXP
    $ADGI
    $AFRM
    $ALLE

    CompanyDatePrice TargetRatingAnalyst
    Saia Inc.
    $SAIA
    2/11/2026$425.00Positive → Neutral
    Susquehanna
    Saia Inc.
    $SAIA
    2/10/2026$250.00Equal-Weight → Underweight
    Morgan Stanley
    Jumia Technologies AG
    $JMIA
    2/6/2026$18.00Overweight
    Cantor Fitzgerald
    Allbirds Inc.
    $BIRD
    2/4/2026Buy → Hold
    Maxim Group
    Affirm Holdings Inc.
    $AFRM
    2/3/2026$76.00Equal-Weight → Overweight
    Morgan Stanley
    United Parcel Service Inc.
    $UPS
    1/28/2026Hold → Buy
    HSBC Securities
    Synchrony Financial
    $SYF
    1/28/2026$96.00Neutral → Buy
    Compass Point
    Apellis Pharmaceuticals Inc.
    $APLS
    1/28/2026$24.00Equal Weight
    Barclays
    More analyst ratings

    $ACXP
    $ADGI
    $AFRM
    $ALLE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Saia downgraded by Susquehanna with a new price target

    Susquehanna downgraded Saia from Positive to Neutral and set a new price target of $425.00

    2/11/26 7:50:53 AM ET
    $SAIA
    Trucking Freight/Courier Services
    Industrials

    Saia downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Saia from Equal-Weight to Underweight and set a new price target of $250.00

    2/10/26 2:29:18 PM ET
    $SAIA
    Trucking Freight/Courier Services
    Industrials

    Cantor Fitzgerald initiated coverage on Jumia with a new price target

    Cantor Fitzgerald initiated coverage of Jumia with a rating of Overweight and set a new price target of $18.00

    2/6/26 8:11:07 AM ET
    $JMIA
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ACXP
    $ADGI
    $AFRM
    $ALLE
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Cadre Holdings Inc.

    SCHEDULE 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/12/26 4:13:47 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Arhaus Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Arhaus, Inc. (0001875444) (Filer)

    2/12/26 4:01:38 PM ET
    $ARHS
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 8-K filed by Canadian Pacific Kansas City Limited

    8-K - CANADIAN PACIFIC KANSAS CITY LTD/CN (0000016875) (Filer)

    2/12/26 12:27:55 PM ET
    $CP
    Railroads
    Industrials

    $ACXP
    $ADGI
    $AFRM
    $ALLE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for EMPAVELI issued to APELLIS PHARMACEUTICALS INC

    Submission status for APELLIS PHARMACEUTICALS INC's drug EMPAVELI (ORIG-1) with active ingredient PEGCETACOPLAN has changed to 'Approval' on 05/14/2021. Application Category: NDA, Application Number: 215014, Application Classification: Type 1 - New Molecular Entity

    5/17/21 11:09:40 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACXP
    $ADGI
    $AFRM
    $ALLE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Human Resources Off Sathyanarayanan Bala bought $158,645 worth of Class B Common Stock (1,819 units at $87.22), increasing direct ownership by 27% to 8,549 units (SEC Form 4)

    4 - GREIF, INC (0000043920) (Issuer)

    2/11/26 5:15:33 PM ET
    $GEF

    EVP, Chief Human Resources Off Sathyanarayanan Bala bought $159,542 worth of Class B Common Stock (1,811 units at $88.10), increasing direct ownership by 37% to 6,730 units (SEC Form 4)

    4 - GREIF, INC (0000043920) (Issuer)

    2/6/26 4:47:40 PM ET
    $GEF

    EVP, Chief Human Resources Off Sathyanarayanan Bala bought $26,614 worth of Class B Common Stock (300 units at $88.71) and sold $992,419 worth of shares (13,337 units at $74.41), decreasing direct ownership by 27% to 36,807 units (SEC Form 4)

    4 - GREIF, INC (0000043920) (Issuer)

    2/5/26 2:45:27 PM ET
    $GEF

    $ACXP
    $ADGI
    $AFRM
    $ALLE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Vice Chair Runkel Mark G. was granted 19,099 shares, increasing direct ownership by 20% to 116,827 units (SEC Form 4)

    4 - US BANCORP \DE\ (0000036104) (Issuer)

    2/12/26 4:48:36 PM ET
    $USB
    Major Banks
    Finance

    Vice Chair Richard Jodi L was granted 41,138 shares, increasing direct ownership by 20% to 247,790 units (SEC Form 4)

    4 - US BANCORP \DE\ (0000036104) (Issuer)

    2/12/26 4:47:35 PM ET
    $USB
    Major Banks
    Finance

    President & CEO Kedia Gunjan was granted 51,423 shares, increasing direct ownership by 16% to 375,321 units (SEC Form 4)

    4 - US BANCORP \DE\ (0000036104) (Issuer)

    2/12/26 4:46:32 PM ET
    $USB
    Major Banks
    Finance

    $ACXP
    $ADGI
    $AFRM
    $ALLE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Allegion to Attend 2026 Barclays Industrial Select Conference

    Allegion plc (NYSE:ALLE) President and CEO John H. Stone will discuss the company's long-term strategy at the 2026 Barclays Industrial Select Conference on Thursday, Feb. 19. The conference will be held at Loews Miami Beach Hotel. A live listen-only webcast will be accessible via Allegion's investor website at investor.allegion.com or directly by clicking here. About Allegion At Allegion (NYSE:ALLE), we design and manufacture innovative security and access solutions that help keep people safe where they live, learn, work and connect. We're pioneering safety with our strong legacy of leading brands like CISA®, Interflex®, LCN®, Schlage®, SimonsVoss® and Von Duprin®. Our comprehensive p

    2/12/26 5:00:00 PM ET
    $ALLE
    Diversified Commercial Services
    Consumer Discretionary

    Arhaus Appoints Michael Rengel as Chief Merchandising Officer

    BOSTON HEIGHTS, Ohio, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, announced that Michael Rengel has been appointed Chief Merchandising Officer, effective February 23, 2026. In this role, Michael will lead Arhaus' merchandising and product strategy across furniture and décor categories, supporting the Company's continued focus on assortment differentiation, product leadership, and disciplined growth. Michael will report to John Reed, Founder and Chief Executive Officer, and will oversee Product Development and Merchandising. Michael brings more tha

    2/12/26 4:01:00 PM ET
    $ARHS
    Other Specialty Stores
    Consumer Discretionary

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    $ACXP
    $ADGI
    $AFRM
    $ALLE
    Leadership Updates

    Live Leadership Updates

    View All

    Arhaus Appoints Michael Rengel as Chief Merchandising Officer

    BOSTON HEIGHTS, Ohio, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, announced that Michael Rengel has been appointed Chief Merchandising Officer, effective February 23, 2026. In this role, Michael will lead Arhaus' merchandising and product strategy across furniture and décor categories, supporting the Company's continued focus on assortment differentiation, product leadership, and disciplined growth. Michael will report to John Reed, Founder and Chief Executive Officer, and will oversee Product Development and Merchandising. Michael brings more tha

    2/12/26 4:01:00 PM ET
    $ARHS
    Other Specialty Stores
    Consumer Discretionary

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Mirion Announces Executive Appointments to Accelerate Strategic Growth and Market Focus

    Tighe Smith assumes newly created role of Chief Nuclear Officer to lead holistic global nuclear strategy. Shelia Webb transitions to President, Nuclear Medicine to lead strategic development of growing market. Shahmeer Mirza appointed first Chief Artificial Intelligence & Digital Officer to drive enterprise AI and operational excellence at Mirion. Combined, appointments reinforce Mirion's near-term execution and long-term, future-minded growth strategy. Mirion (NYSE:MIR), a global leader in radiation detection, measurement, analysis and monitoring solutions for the nuclear, medical, defense and research end markets, today announced three new leadership appointments supporting t

    2/11/26 9:19:00 AM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    $ACXP
    $ADGI
    $AFRM
    $ALLE
    Financials

    Live finance-specific insights

    View All

    Hyatt Reports Fourth Quarter and Full Year 2025 Results

    Hyatt Hotels Corporation ("Hyatt," "the Company," "we," "us," or "our") (NYSE:H) today reported fourth quarter and full year 2025 results. Highlights include: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212984481/en/Hyatt's Fourth Quarter and Full Year 2025 Infographic Comparable system-wide hotels RevPAR growth was 4.0% in the fourth quarter and 2.9% for the full year of 2025, compared to the same periods in 2024 Comparable system-wide all-inclusive resorts Net Package RevPAR growth was 8.3% in the fourth quarter and 8.6% for the full year of 2025, compared to the same periods in 2024 Net rooms growth was 7.3% for

    2/12/26 6:55:00 AM ET
    $H
    Hotels/Resorts
    Consumer Discretionary

    MGP Ingredients to Report Fourth Quarter and Full Year Financial Results on Wednesday, February 25, 2026

    MGP Ingredients, Inc. (NASDAQ:MGPI), a leading provider of branded and distilled spirits and food ingredient solutions, today announced that it will report results for the fourth quarter and full year ended December 31, 2025, on Wednesday, February 25, at 10 a.m. ET. The company expects to release its financial results before the markets open. Management, including Julie Francis, President and CEO, Brandon Gall, CFO, will hold a conference call to discuss these results. Please visit the "News and Events" section of the company's Investor Relations section at ir.mgpingredients.com/news-events to access the live webcast. Investors can also dial 844-308-6398 (domestic) or 412-717-9605 (int

    2/11/26 5:30:00 PM ET
    $MGPI
    Beverages (Production/Distribution)
    Consumer Staples

    Copa Holdings Reports Fourth-Quarter and Full-Year 2025 Financial Results

    PANAMA CITY, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Copa Holdings1, S.A. (NYSE:CPA) today announced financial results for the fourth quarter (4Q25) and full year 2025, closing another year of industry-leading profitability and operational excellence. Key highlights include: Fourth Quarter 2025 Net profit of US$172.6 million, or US$4.18 per share, representing a 5.3% year‑over‑year increase in earnings per share. Excluding a US$7.2 million non‑cash, maintenance‑related adjustment to the provision for future leased‑aircraft return obligations, as well as a US$6.0 million foreign‑currency loss mainly due to volatility in the Brazilian real, EPS for the quarter would have been US$4.46, a 12.3% i

    2/11/26 4:30:00 PM ET
    $CPA
    Air Freight/Delivery Services
    Consumer Discretionary

    $ACXP
    $ADGI
    $AFRM
    $ALLE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Inozyme Pharma Inc.

    SC 13G - Inozyme Pharma, Inc. (0001693011) (Subject)

    12/9/24 4:14:49 PM ET
    $INZY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Apellis Pharmaceuticals Inc.

    SC 13G/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 4:16:13 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Apellis Pharmaceuticals Inc.

    SC 13G - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 8:47:59 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care